StockClub

KROS

KROSKeros Therapeutics, Inc.$ --
Keros Therapeutics, Inc.

Keros Therapeutics, Inc.

KROS

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 05/14/2026FY2026 Q1
Revenue
0M USD
YoY -99.8%
Operating Income
-26M USD
YoY -117.0%
Net Income
-24M USD
YoY -116.0%
EPS
-0.64$
YoY -117.5%

Revenue

$367,000
FY2024 Q2$120,000
$120,000
Q2
FY2024 Q3$508,000
$508,000
Q3
FY2024 Q4$3.5M
$3.5M
Q4
FY2025 Q1$211.2M
$211.2M
Q1
FY2025 Q2$229.4M
$229.4M
Q2
FY2025 Q3$243.7M
$243.7M
Q3
FY2025 Q4$244.1M
$244.1M
Q4
FY2026 Q1$367,000
$367,000
Q1
Actual
$-210.9M (-99.8%)

Net Income

$-23.7M
FY2024 Q2$-88.4M
$-88.4M
Q2
FY2024 Q3$-141.3M
$-141.3M
Q3
FY2024 Q4$-187.4M
$-187.4M
Q4
FY2025 Q1$148.5M
$148.5M
Q1
FY2025 Q2$117.8M
$117.8M
Q2
FY2025 Q3$110.5M
$110.5M
Q3
FY2025 Q4$87M
$87M
Q4
FY2026 Q1$-23.7M
$-23.7M
Q1
Actual
$-172.2M (-116.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021BEAT
Actual:$20.1M
Est:$100,000
FY2021BEAT
$20.1M
FY2022MISS
Actual:$0
Est:$1M
FY2022MISS
$0
FY2023MISS
Actual:$151,000
Est:$271,000
FY2023MISS
$151,000
FY2024BEAT
Actual:$3.5M
Est:$554,000
FY2024BEAT
$3.5M
FY2025MISS
Actual:$244.1M
Est:$245.9M
FY2025MISS
$244.1M

Analyst Estimates

Earnings Release History